AzTrials
AzTrials

Substance-Related DisordersNCT00957775

Computer-delivered Psychosocial Intervention for Adolescent Substance Use Disorders

A study testing Computer-delivered ACRA in people with Substance-Related Disorders and Alcohol-Related Disorders, run by National Development and Research Institutes, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to develop and evaluate the acceptability and preliminary efficacy of a web-based, skills training program for adolescents with substance use disorders. Read more about this study

Who is it for?
Ages 12 to 18 years
What is being tested?
Computer-delivered ACRA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteUnited States
Study dates
Aug 2009to Jul 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Clinical diagnosis of non-nicotine alcohol or drug use disorder
  • English speaking
  • Parental consent to participate for adolescents under the age of 18.

Who cannot join

  • Clinical diagnosis of psychiatric disorders that require intensive level of services, such as active psychosis, active mania or active suicidality
  • Plan to move out of the area within the next 3 months
  • Insufficient ability to understand and provide informed consent/assent to participate
  • Lack sufficient ability to use English to participate in the consent/assent process, the interventions or assessments

Trial locations and contacts

1 site in 1 country.

Michelle Acosta, Ph.D. contact

212-845-4535

acosta@ndri.org

United States1 site
  • National Development and Research Institutes, Inc.; St. Luke's-Roosevelt Hospital Center

    New York, New York, 10010; 10025

    Ramon Solhkhah, MD

Other trials in United States

About this study

The purpose of this study is to develop and evaluate the acceptability and preliminary efficacy of a web-based, skills training program for adolescents with substance use disorders.

Read the detailed description

Substance use among youth remains a major public health problem. About half of all 12th graders have tried an illicit drug and over 72% of this same age group have used alcohol. Rates of abuse of prescription opioids among youth are estimated to have increased about 542% in the past decade. Although effective substance abuse treatment programs for youth exist, they are currently of limited reach. Only 1 in 10 adolescents who need substance abuse treatment receive any care. An interactive, computer-delivered psychosocial (skills-training) intervention has the potential to address these challenges, as it allows for complex interventions to be delivered at a low cost, without increasing demands on staff time or training needs. It may also be highly acceptable to youth and enable widespread dissemination of science-based treatment in a manner that ensures fidelity.

In this project, we plan to develop and evaluate the acceptability and preliminary efficacy of a web-based, skills training program for adolescents with substance use disorders. The content of this program will be based in a model of psychosocial substance abuse treatment for youth that has been shown to be effective in prior scientific research. It will be provided via an interactive, delivery system that employs informational technologies that are effective in promoting relevant knowledge and skills. Adolescents in substance abuse treatment will help shape the development of this program. To our knowledge, the planned program will be the first interactive program to provide comprehensive, psychosocial substance abuse treatment to adolescents via computer-based technology.

This research will contribute new information relevant to increasing the delivery of science-based psychosocial treatment to adolescents with substance use disorders in a manner that is cost-effective and which may promote the adoption of effective treatment.

Being tested
Usual care, Computer-delivered ACRA
Keywords
Substance Abuse Treatment, Adolescents, Substance-Related Disorders, Alcohol-Related Disorders, Marijuana Abuse
Medical subject headings
Substance-Related Disorders, Alcohol-Related Disorders, Marijuana Abuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Usual careBehavioural

    Also called treatment-as-usual (TAU)

    Participants will receive the usual care (e.g., individual therapy, group therapy, family therapy, self-help groups) provided at the treatment site.

  • Computer-delivered ACRABehavioural

    Participants and willing caregivers will receive a computer-delivered intervention for 12 weeks, based on the Adolescent Community Reinforcement Approach to substance abuse treatment.

Study groups in NCT00957775
Study groupRoleWhat they receive
Usual careActive comparatorParticipants will receive the usual care (e.g., individual therapy, group therapy, self-help groups) provided at the treatment site.
Receives: Behavioral: Usual care
Computer-delivered ACRAExperimentalParticipants and willing caregivers will receive a computer-delivered intervention for 12 weeks, based on the Adolescent Community Reinforcement Approach to substance abuse treatment.
Receives: Behavioral: Computer-delivered ACRA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. substance use

    Measured: 16 weeks

  2. acceptability of intervention

    Measured: 12 weeks

Secondary outcomes (2)
  1. HIV risk behavior

    Measured: 16 weeks

  2. psychosocial functioning

    Measured: 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2009 (estimated)
  2. Study startAug 2009
  3. Primary completionJul 2011 (estimated)
  4. Study completionJul 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00957775
Sponsor's protocol ID
R01DA025072
Other IDs
R01DA025072
Status last verified
Aug 2009
First submitted
11 Aug 2009
Last updated
12 Aug 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Computer-delivered ACRA in people with Substance-Related Disorders and Alcohol-Related Disorders, run by National Development and Research Institutes, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Aug 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michelle Acosta, Ph.D. (212-845-4535, acosta@ndri.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

substance use (time frame: 16 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in